Editor's Note New research from the American College of Surgeons and American Cancer Society describes ways the National Cancer Database (NCDB) was impacted by the COVID-19 pandemic. For the study, researchers reviewed 4,045,097 cancer cases of adults 18 years or older who were diagnosed with cancer and/or received their first-course…

Read More

Editor's Note This study led by researchers at Columbia University Irving Medical Center, New York City, finds that race, ethnicity, and area-level social determinants of health (SDOH) were associated with delayed or discontinued cancer treatments and longer delays to restart drug-based therapies after COVID-19 infections. The analysis included data on…

Read More

Editor's Note Strides have been made in cancer treatments, diagnostic tools and prevention strategies, driving down cancer death rates, according to a report published Wednesday, September 21, by the American Association for Cancer Research, NBC News September 21 reports. According to the group’s annual Cancer Progress Report, over the past…

Read More

Cancer treatment delays in COVID-19 patients This large prospective cohort study from the Memorial Sloan Kettering Cancer Center, New York City, found that multiple patient factors, underlying primary malignant neoplasm, multimorbidity, geographic location, receipt of vaccine, and COVID-19 severity and diagnosis date were linked to delays in cancer treatment during…

Read More